BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2418464)

  • 21. Interleukin 2 acts directly on a Tac-positive cloned B cell line established from a patient with adult T cell leukemia.
    Arima N; Daitoku Y; Hidaka S; Tanaka H; Katsuki T
    J Immunol; 1985 Oct; 135(4):2474-7. PubMed ID: 2863306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expression and regulation of c-myb transcription in B6/lpr Lyt-2-, L3T4-T lymphocytes.
    Yokota S; Yuan D; Katagiri T; Eisenberg RA; Cohen PL; Ting JP
    J Immunol; 1987 Oct; 139(8):2810-7. PubMed ID: 3116095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes.
    Kurki P; Lotz M; Ogata K; Tan EM
    J Immunol; 1987 Jun; 138(12):4114-20. PubMed ID: 2884260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation.
    Waldmann TA; Tsudo M
    Prog Clin Biol Res; 1988; 262():283-93. PubMed ID: 2897696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
    Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG
    J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of interleukin 2 receptor acquisition by monoclonal antibodies recognizing the 50 KD protein associated with the sheep erythrocyte receptor on human T lymphocytes.
    Reed JC; Tadmori W; Kamoun M; Koretzky G; Nowell PC
    J Immunol; 1985 Mar; 134(3):1631-9. PubMed ID: 2981917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two pathways of T cell activation.
    Meuer SC; Hauer M; Deusch K; Moebius U; Meyer zum Büschenfelde KH
    Behring Inst Mitt; 1987 Jun; (81):15-30. PubMed ID: 3115246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interleukin 2 receptor and its physiology. Implications for combatting autoimmune diseases and transplant rejections.
    Diamantstein T
    Behring Inst Mitt; 1987 Jun; (81):73-87. PubMed ID: 3115248
    [No Abstract]   [Full Text] [Related]  

  • 29. Activated human B cells display a functional IL 2 receptor.
    Mittler R; Rao P; Olini G; Westberg E; Newman W; Hoffmann M; Goldstein G
    J Immunol; 1985 Apr; 134(4):2393-9. PubMed ID: 2982945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of interleukin 2 and interleukin 2 receptor gene expression in human T cells: I. Effect of Ca2+-ionophore on phorbol myristate acetate co-stimulated cells.
    Chopra RK; Nagel JE; Chrest FJ; Boto WM; Pyle RS; Dorsey B; McCoy M; Holbrook N; Adler WH
    Clin Exp Immunol; 1987 Aug; 69(2):433-40. PubMed ID: 3115657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression.
    Reed JC; Abidi AH; Alpers JD; Hoover RG; Robb RJ; Nowell PC
    J Immunol; 1986 Jul; 137(1):150-4. PubMed ID: 3011905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin 2 receptor (Tac antigen) expression in HTLV-I-associated adult T-cell leukemia.
    Waldmann TA; Longo DL; Leonard WJ; Depper JM; Thompson CB; Krönke M; Goldman CK; Sharrow S; Bongiovanni K; Greene WC
    Cancer Res; 1985 Sep; 45(9 Suppl):4559s-4562s. PubMed ID: 2990687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of anti-CD3 (T3) antibody-induced activation of T cells by cyclosporine.
    Bentin J; Carson DA; Vaughan JH; Tsoukas CD
    Transplantation; 1986 Sep; 42(3):317-20. PubMed ID: 3092413
    [No Abstract]   [Full Text] [Related]  

  • 34. Human interleukin 2: molecular biology, physiology and clinical possibilities.
    Mertelsmann R; Welte K
    Immunobiology; 1986 Sep; 172(3-5):400-19. PubMed ID: 3100434
    [No Abstract]   [Full Text] [Related]  

  • 35. Reconstitution of high affinity IL-2 receptor expression in a human T-cell line using a retroviral cDNA expression vector.
    Wano Y; Cullen BR; Svetlik PA; Peffer NJ; Greene WC
    Mol Biol Med; 1987 Apr; 4(2):95-109. PubMed ID: 3114593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo and in vitro expression of an interleukin 2 receptor by murine B and T lymphocytes.
    Finkelman FD; Malek TR; Shevach EM; Mond JJ
    J Immunol; 1986 Oct; 137(7):2252-9. PubMed ID: 3093569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes.
    Waldmann TA
    Science; 1986 May; 232(4751):727-32. PubMed ID: 3008337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of the human interleukin-2 receptor: molecular, biochemical, and functional properties.
    Greene WC
    Cancer Invest; 1987; 5(4):369-76. PubMed ID: 2889515
    [No Abstract]   [Full Text] [Related]  

  • 39. Phorbol esters, lipopolysaccharides and colony stimulating factor production.
    Pluznik DH; Bickel M
    Prog Clin Biol Res; 1990; 352():205-13. PubMed ID: 2205862
    [No Abstract]   [Full Text] [Related]  

  • 40. IL-2 receptor dysfunction and adult T-cell leukemia.
    Yodoi J; Uchiyama T
    Immunol Rev; 1986 Aug; 92():135-56. PubMed ID: 2875026
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.